C17H 21 ClN 2 S, orthorhombic, Pbca (no. 61), a = 17.2134(6) Å,
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Source of material
4-Chlorophenyl isothiocyanate (1.70 g, 0.01 mol) was added to a solution of 1-adamantylamine (1.51 mg, 0.01 mol), in ethanol (15 mL), and the mixture was heated under re ux for 2 h. The mixture was then concentrated to half the original 
Atom Site
x y z U U U U U U S( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) N( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) N( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) Cl( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) − . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) − . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) c .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) − . ( ) C( ) c . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) c .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .
Experimental details
Cell re nement and data reduction were carried out by Bruker SAINT [22] . The carbon-bound hydrogen atoms were idealized and re ned using a riding model (AFIX 13, AFIX 23 or AFIX 43 option of the SHELX programm [23] . Nitrogen-bound hydrogen atoms were re ned freely.
Discussion
Several adamantane-based drugs as amantadine [1, 2] , rimantadine [3, 4] and tromantadine [5] are currently employed as e cient antiviral agents. In addition, numerous adamantanebased drugs are currently used as important medications against malaria [6] , central nervous disorders [7] [8] [9] , hyperglycaemia [10] and drug-resistant TB strain infections [11] . Moreover, thiourea derivatives were reported to possess marked anticancer [12] , anti-HIV [13] , antimalarial [14] and antimicrobial [15] activities. As a part of our current research interest in the pharmacological [16] [17] [18] and structural [19] [20] [21] properties of adamantane derivatives, we report herein the synthesis and crystal structure of the potentially bioactive title compound. The molecules packing in the crystal structure is stabilized via two intermolecular hydrogen bonds, of which S1 work as hydrogen bond acceptor and the NH groups of N1 and N2 work as hydrogen bond donors. The distance of the interactions between N1-H1N1· · · S1
i and N2-H1N2· · · S1 i are 2.534(14) and 2.615(14) Å, respectively and the angles are 163.1 (12) and 159.9(12)°, respectively. Symmetry codes: (i) −x+3/2, y−1/2, z.
